Background illustration for clinical trials search

Paid Clinical Trials Alberta

Discover 833 paid clinical trials in Alberta . Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

for
Metastatic Dedifferentiated Liposarcoma,
Location: Boston MA, Waterford CT, Guilford CT, New Haven CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06422806

Phase3, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

for
Crohn's Disease
Location: Kentville, Boston MA, Providence RI, Levis,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 16 - 70+

Code: NCT06430801

Phase3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: South Dartmouth MA, New Haven CT, Manhasset NY,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase3, Recruiting
Active & Responsive

Predictors of Relapse in Major Depressive Disorder (PERFORM-D)

for
Major Depressive Disorder (MDD)
Location: Halifax, Kingston, Whitby, Toronto, Hamilton, Calgary,
Sponsor: Abraham Nunes

Sex: All

Age: 18 - 70

Code: NCT06746155

Recruiting
Active & Responsive

Use of Passive Myofunctional Appliances for Snoring and Mild Obstructive Sleep Apnea

for
Sleep Apnea, Obstructive
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT05497180

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: New Bedford MA, New Haven CT, Manhasset NY, New York NY,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase3, Recruiting
Active & Responsive

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

for
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation
Location: Portland ME, Boston MA, Worcester MA, Lebanon NH,
Sponsor: Chris Goss

Sex: All

Age: 6+

Code: NCT05548283

Recruiting
Active & Responsive

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

for
Triple Negative Breast Neoplasms
Location: Quebec, Chicoutimi, Mineola NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06841354

Phase3, Recruiting
Active & Responsive

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis
Location: Boston MA, Quebec, Washington D.C. DC, Ottawa,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06744920

Phase3, Recruiting
Active & Responsive

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

for
Moderate to Severe Chronic Obstructive Pulmonary Disease
Location: Greenacres City FL, Loxahatchee Groves FL, Miami FL,
Sponsor: Pfizer

Sex: All

Age: 35 - 70+

Code: NCT07363694

Phase2, Phase3, Recruiting
Active & Responsive

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

for
Non-segmental Vitiligo
Location: The Bronx NY, Quebec, Norfolk VA, Hollywood FL,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07431177

Phase2, Recruiting
Active & Responsive

Implementation and Evaluation of a Pharmacist-led Diabetes Care Pathway in Alberta Community Pharmacies

for
Diabetes Mellitus, Hypertension, Hyperlipidaemia
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT07339852

Recruiting
Active & Responsive

Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)

for
Major Depressive Disorder
Location: Halifax, Ottawa, Kingston, Whitby, Toronto, Hamilton,
Sponsor: Nova Scotia Health Authority

Sex: All

Age: 18 - 65

Code: NCT05017311

Recruiting
Active & Responsive

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

for
Diabetic Nephropathies, Kidney Failure, Chronic,
Location: Boston MA, The Bronx NY, Montreal, Syracuse NY, Toronto,
Sponsor: Alessandro Doria

Sex: All

Age: 18 - 70+

Code: NCT06217302

Phase3, Recruiting
Active & Responsive

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

for
Cardiovascular Disease
Location: Boston MA, East Greenwich RI, Hamden CT, Sherbrooke,
Sponsor: Amgen

Sex: All

Age: 50 - 70+

Code: NCT07136012

Phase3, Recruiting
Active & Responsive

Brief Skills for Safer Living (Brief-SfSL)

for
Suicide Prevention, Suicide, Suicide and Self-harm, Depression,
Location: St. John's, Grand Falls-Windsor, Corner Brook,
Sponsor: Unity Health Toronto

Sex: All

Age: 18+

Code: NCT06571916

Recruiting
Active & Responsive

Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants

for
Inherited Retinal Degeneration, Retinitis Pigmentosa
Location: Boston MA, Philadelphia PA, Baltimore MD, Durham NC,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 4+

Code: NCT05589714

Recruiting
Active & Responsive

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

for
Plaque Psoriasis
Location: Boston MA, Cromwell CT, Quebec, New York NY, Montreal,
Sponsor: Oruka Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07449702

Phase2, Recruiting
Active & Responsive

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

for
Atherosclerotic Cardiovascular Disease, Overweight, Obesity
Location: Moncton, New Bedford MA, Boston MA, East Greenwich RI,
Sponsor: Amgen

Sex: All

Age: 45 - 70+

Code: NCT07037433

Phase3, Recruiting
Active & Responsive

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

for
Heart Failure With Preserved Ejection Fraction,
Location: Sherbrooke, Chicoutimi, Stamford CT, New York NY,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07037459

Phase3, Recruiting